120 related articles for article (PubMed ID: 10931166)
1. Acquired haemophilia complicating the remission of a patient with high grade non-Hodgkin's lymphoma treated by fludarabine.
Tiplady CW; Hamilton PJ; Galloway MJ
Clin Lab Haematol; 2000 Jun; 22(3):163-5. PubMed ID: 10931166
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic pneumonia after administration of fludarabine for the treatment of non-Hodgkin's lymphoma.
Trojan A; Meier R; Licht A; Taverna C
Ann Hematol; 2002 Sep; 81(9):535-7. PubMed ID: 12373357
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune thrombocytopenia associated with the first cycle of fludarabine therapy in the treatment of relapsed non-Hodgkin's lymphoma.
Churn M; Clough V
Clin Oncol (R Coll Radiol); 2001; 13(4):273-5. PubMed ID: 11554624
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine: a review of its use in non-Hodgkin's lymphoma.
Anderson VR; Perry CM
Drugs; 2007; 67(11):1633-55. PubMed ID: 17661532
[TBL] [Abstract][Full Text] [Related]
5. [A clinical observation of fludarabine-containing regimens in the treatment of low grade non-Hodgkin's lymphoma].
Lü SQ; Yang JM; Song XM; Chen L; Zhang WP; Ni X; Xu XQ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):710-2. PubMed ID: 18246806
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma.
Yavuz S; Paydas S; Disel U; Sahin B
Leuk Lymphoma; 2003 Jul; 44(7):1249-50. PubMed ID: 12916882
[No Abstract] [Full Text] [Related]
7. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
[TBL] [Abstract][Full Text] [Related]
8. Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.
Hochster HS; Kim KM; Green MD; Mann RB; Neiman RS; Oken MM; Cassileth PA; Stott P; Ritch P; O'Connell MJ
J Clin Oncol; 1992 Jan; 10(1):28-32. PubMed ID: 1727921
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic pemphigus associated with fludarabine use.
Yildiz O; Ozguroglu M; Yanmaz MT; Turna H; Kursunoglu SG; Antonov M; Serdaroglu S; Demirkesen C; Buyukunal E
Med Oncol; 2007; 24(1):115-8. PubMed ID: 17673821
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis-associated fatal hemophagocytic syndrome in a patient with lymphoma treated with fludarabine.
Ruiz-Argüelles GJ; Arizpe-Bravo D; Garcés-Eisele J; Sánchez-Sosa S; Ruiz-Argüelles A; Ponce-de-León S
Leuk Lymphoma; 1998 Feb; 28(5-6):599-602. PubMed ID: 9613991
[TBL] [Abstract][Full Text] [Related]
11. Fulminant hepatic failure secondary to adenovirus following fludarabine-based chemotherapy for non-Hodgkin's lymphoma.
Hogan WJ; Edwards WD; Macon WR; Habermann TM
Leuk Lymphoma; 2001; 42(5):1145-50. PubMed ID: 11697635
[TBL] [Abstract][Full Text] [Related]
12. Low-grade non Hodgkin's lymphomas in the elderly: impact of a low-dose fludarabine-based combination regimen (mini-FLEC).
Bocchia M; Gentili S; Forconi F; le Noci M; Tozzi M; Lauria F
Haematologica; 2003 Mar; 88(3):358-60. PubMed ID: 12651282
[No Abstract] [Full Text] [Related]
13. Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma.
Hendry L; Bowen A; Matutes E; Swansbury J; Catovsky D
Leuk Lymphoma; 2004 May; 45(5):945-50. PubMed ID: 15291353
[TBL] [Abstract][Full Text] [Related]
14. Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease.
Bendandi M; Zaccaria A; Zinzani PL; Visani G; Stefanati V; Cantagalli F; Mancino A; Macchi S; Simoncelli F; Tura S
Leuk Lymphoma; 1995 Feb; 16(5-6):511-3. PubMed ID: 7540464
[TBL] [Abstract][Full Text] [Related]
15. The combination of fludarabine and cyclophosphamide results in a high remission rate with moderate toxicity in low-grade non-Hodgkin's lymphomas.
Eucker J; Schille C; Schmid P; Jakob C; Schetelig J; Kingreen D; Mergenthaler HG; Huhn D; Possinger K; Sezer O
Anticancer Drugs; 2002 Oct; 13(9):907-13. PubMed ID: 12394253
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine single-agent therapy for relapsed low-grade non-Hodgkin's lymphomas: a phase II study of the German Low-Grade Non-Hodgkin's Lymphoma Study Group.
Hiddemann W; Unterhalt M; Pott C; Wörmann B; Sandford D; Freund M; Engert A; Gassmann W; Holtkamp W; Seufert J
Semin Oncol; 1993 Oct; 20(5 Suppl 7):28-31. PubMed ID: 8235693
[TBL] [Abstract][Full Text] [Related]
17. Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL).
Braess J; Reich K; Willert S; Strutz F; Neumann C; Hiddemann W; Wörmann B
Ann Hematol; 1997; 75(5-6):227-30. PubMed ID: 9433380
[TBL] [Abstract][Full Text] [Related]
18. Second primary tumors and immune phenomena after fludarabine or 2-chloro-2'-deoxyadenosine treatment.
Van Den Neste E; Delannoy A; Feremans W; Ferrant A; Michaux L
Leuk Lymphoma; 2001 Feb; 40(5-6):541-50. PubMed ID: 11426527
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphoma.
Abbasi MR; Sparano JA; Sarta C; Wiernik PH
Med Oncol; 2003; 20(1):53-8. PubMed ID: 12665685
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms.
Abruzzo LV; Rosales CM; Medeiros LJ; Vega F; Luthra R; Manning JT; Keating MJ; Jones D
Am J Surg Pathol; 2002 May; 26(5):630-6. PubMed ID: 11979093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
